Torsten Malmström
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Torsten Malmström formerly worked at Zealand Pharma A, as Director-Pharmaceutical Development, PolyPeptide Laboratories (Sweden) AB, as Development Director, AstraZeneca AB, as Team Manager, and Camurus AB, as Vice President-Technical Operations.
Dr. Malmström received his doctorate degree from the University of Lund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAMURUS AB 0,06 % | 31/12/2024 | 35 363 ( 0,06 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
| CAMURUS AB | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national